洁特生物
(688026)
| 流通市值：18.82亿 | | | 总市值：18.84亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 467,051,911.16 | 491,681,992.86 | 520,200,418.65 | 539,133,692.05 |
| 应收票据及应收账款 | 136,701,788.26 | 108,700,571.56 | 106,027,611.95 | 127,541,590.16 |
| 应收账款 | 136,701,788.26 | 108,700,571.56 | 106,027,611.95 | 127,541,590.16 |
| 预付款项 | 27,758,229.85 | 46,335,633.77 | 8,129,424.8 | 5,329,774.69 |
| 其他应收款合计 | 10,243,116.81 | 13,628,102.8 | 6,567,250.8 | 4,736,626.48 |
| 存货 | 110,341,988.6 | 96,313,859.74 | 91,961,758.8 | 84,481,357.87 |
| 其他流动资产 | 12,948,801.23 | 11,325,176.09 | 11,540,487.14 | 9,724,839.32 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 765,045,835.91 | 767,985,336.82 | 744,426,952.14 | 770,947,880.57 |
| 非流动资产: | | | | |
| 长期股权投资 | 38,672,805.36 | 32,958,059.02 | 32,969,369.02 | 33,267,970.98 |
| 其他权益工具投资 | 28,648,010.52 | 28,735,525.68 | 28,700,225.77 | 28,766,904.16 |
| 投资性房地产 | 178,613,484.75 | 180,148,852.77 | 181,834,888.44 | 183,359,308.78 |
| 固定资产 | 414,616,246.51 | 419,318,155.95 | 376,539,487.76 | 385,890,248.82 |
| 在建工程 | 119,563,539.22 | 98,744,447.3 | 145,689,350.65 | 117,842,247.56 |
| 使用权资产 | 405,569.08 | 856,630.79 | 1,154,137.18 | 2,245,358.26 |
| 无形资产 | 52,666,819.33 | 52,980,250.28 | 53,293,681.23 | 53,638,133.39 |
| 递延所得税资产 | 5,610,147.64 | 5,325,817.45 | 5,602,315.35 | 5,592,313.59 |
| 其他非流动资产 | 27,105,724.81 | 37,695,061.61 | 40,315,801.58 | 44,501,844.5 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 865,902,347.22 | 856,762,800.85 | 866,099,256.98 | 855,104,330.04 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,630,948,183.13 | 1,624,748,137.67 | 1,610,526,209.12 | 1,626,052,210.61 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 28,438,544.17 | 36,362,244.6 | 27,345,280.97 | 39,149,751.91 |
| 应付账款 | 28,438,544.17 | 36,362,244.6 | 27,345,280.97 | 39,149,751.91 |
| 预收款项 | 218,493.32 | 90,217.51 | 279,081.19 | 462,529.31 |
| 合同负债 | 15,608,014.68 | 17,634,128.95 | 33,622,671.06 | 32,329,934.88 |
| 应付职工薪酬 | 9,762,786.33 | 8,751,125.17 | 11,325,634.94 | 11,907,445.44 |
| 应交税费 | 9,319,273.94 | 6,168,036.91 | 4,145,474.15 | 4,967,800.65 |
| 其他应付款合计 | 18,434,897.23 | 24,506,865.53 | 14,351,354.61 | 10,685,743.45 |
| 应付股利 | 1,268,669.28 | 10,014,676.51 | - | - |
| 一年内到期的非流动负债 | 1,683,272.38 | 1,660,139.82 | 2,851,010.72 | 2,847,230.22 |
| 其他流动负债 | 288,957.15 | 319,541.52 | 1,182,957.22 | 1,053,025.23 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 83,754,239.2 | 95,492,300.01 | 95,103,464.86 | 103,403,461.09 |
| 非流动负债: | | | | |
| 应付债券 | 354,093,351.97 | 348,270,499.56 | 342,526,632.62 | 336,845,885.1 |
| 租赁负债 | 87,103.91 | 188,994.38 | 459,634.14 | 506,647.33 |
| 预计负债 | - | - | 1,076,536.34 | 1,009,652.78 |
| 递延收益 | 23,615,819.12 | 24,631,784.66 | 25,647,750.2 | 26,663,715.74 |
| 递延所得税负债 | 35,283.19 | 35,283.19 | 35,283.19 | 35,283.19 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 377,831,558.19 | 373,126,561.79 | 369,745,836.49 | 365,061,184.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 461,585,797.39 | 468,618,861.8 | 464,849,301.35 | 468,464,645.23 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 140,363,220 | 140,363,220 | 140,363,220 | 140,363,220 |
| 其他权益工具 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 |
| 资本公积 | 413,562,031.59 | 413,562,031.59 | 413,562,031.59 | 413,562,031.59 |
| 减:库存股 | 30,000,946.05 | 21,453,047.61 | 20,067,845.19 | - |
| 其他综合收益 | 678,778.95 | 514,596.83 | 535,811.91 | 591,258.54 |
| 盈余公积 | 60,562,454.98 | 60,562,454.98 | 60,562,454.98 | 60,562,454.98 |
| 未分配利润 | 452,123,235.92 | 431,966,650.5 | 420,159,670.65 | 411,981,122.47 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,167,194,311.79 | 1,155,421,442.69 | 1,145,020,880.34 | 1,156,965,623.98 |
| 少数股东权益 | 2,168,073.95 | 707,833.18 | 656,027.43 | 621,941.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,169,362,385.74 | 1,156,129,275.87 | 1,145,676,907.77 | 1,157,587,565.38 |
| 负债和股东权益合计 | 1,630,948,183.13 | 1,624,748,137.67 | 1,610,526,209.12 | 1,626,052,210.61 |
| 公告日期 | 2024-10-24 | 2024-08-24 | 2024-04-27 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |